Taysha Gene Therapies Announces Pricing Of ~$75M Public Offering Of 14,361,113 Shares Of Its Common Stock At A Price To The Public Of $2.25 Per Share
Portfolio Pulse from Benzinga Newsdesk
Taysha Gene Therapies (NASDAQ:TSHA) announced a $75M public offering of 14,361,113 shares at $2.25 per share. The offering includes pre-funded warrants and an option for underwriters to purchase an additional 15% of shares. The offering is expected to close on June 27, 2024.
June 26, 2024 | 1:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Taysha Gene Therapies announced a $75M public offering at $2.25 per share, including pre-funded warrants and an option for underwriters to purchase an additional 15% of shares. The offering is expected to close on June 27, 2024.
The announcement of a public offering typically leads to a short-term decrease in stock price due to dilution concerns. The offering price of $2.25 per share is likely to set a near-term price ceiling.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100